Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Long-term clinical outcomes of statin use for chronic heart failure: a meta-analysis of 15 prospective studies.

Wang JQ, Wu GR, Wang Z, Dai XP, Li XR.

Heart Lung Circ. 2014 Feb;23(2):105-13. doi: 10.1016/j.hlc.2013.07.012. Epub 2013 Aug 17. Review.

PMID:
23962886
2.

Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure.

Vrtovec B, Okrajsek R, Golicnik A, Ferjan M, Starc V, Schlegel TT, Radovancevic B.

J Card Fail. 2008 Mar;14(2):140-4. doi: 10.1016/j.cardfail.2007.10.013.

PMID:
18325461
3.

Efficacy of statin therapy in chronic systolic cardiac insufficiency: a meta-analysis.

Zhang S, Zhang L, Sun A, Jiang H, Qian J, Ge J.

Eur J Intern Med. 2011 Oct;22(5):478-84. doi: 10.1016/j.ejim.2011.06.003. Epub 2011 Jul 16. Review.

PMID:
21925056
4.

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.

Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Fukunami M.

Am Heart J. 2007 Jun;153(6):1055.e1-8.

PMID:
17540209
5.

Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.

Vrtovec B, Okrajsek R, Golicnik A, Ferjan M, Starc V, Radovancevic B.

J Card Fail. 2005 Dec;11(9):684-90.

PMID:
16360963
6.

Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.

Krum H, Bailey M, Meyer W, Verkenne P, Dargie H, Lechat P, Anker S.

Cardiology. 2007;108(1):28-34. Epub 2006 Sep 8.

PMID:
16960445
7.

Class effects of statins in elderly patients with congestive heart failure: a population-based analysis.

Rinfret S, Behlouli H, Eisenberg MJ, Humphries K, Tu JV, Pilote L.

Am Heart J. 2008 Feb;155(2):316-23. doi: 10.1016/j.ahj.2007.09.004. Epub 2007 Oct 25.

PMID:
18215603
8.

Short-term effects of atorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease.

Cunningham SM, Rush JE, Freeman LM.

J Vet Intern Med. 2013 Jul-Aug;27(4):985-9. doi: 10.1111/jvim.12123. Epub 2013 Jun 12.

9.

Impact of adherence to statins on chronic heart failure in primary prevention.

Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M.

Br J Clin Pharmacol. 2008 Nov;66(5):706-16. doi: 10.1111/j.1365-2125.2008.03269.x. Epub 2008 Jul 24.

10.

Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure.

Strey CH, Young JM, Lainchbury JH, Frampton CM, Nicholls MG, Richards AM, Scott RS.

Heart. 2006 Nov;92(11):1603-9. Epub 2006 May 18.

11.

Bias in the evaluation of effects of statins on mortality in patients with heart failure.

White J, Stewart R.

Heart Lung Circ. 2014 Oct;23(10):989-90. doi: 10.1016/j.hlc.2014.04.133. Epub 2014 May 23. No abstract available.

PMID:
24951456
12.

Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.

Anker SD, Clark AL, Winkler R, Zugck C, Cicoira M, Ponikowski P, Davos CH, Banasiak W, Zardini P, Haass M, Senges J, Coats AJ, Poole-Wilson PA, Pitt B.

Int J Cardiol. 2006 Sep 20;112(2):234-42. Epub 2006 Jul 17.

PMID:
16846656
13.

Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.

Sever PS, Poulter NR, Dahlof B, Wedel H; ASCOT Investigators.

J Hypertens. 2009 May;27(5):947-54. doi: 10.1097/HJH.0b013e328326cb1a.

PMID:
19318984
14.

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D.

J Am Coll Cardiol. 2008 Nov 25;52(22):1769-81. doi: 10.1016/j.jacc.2008.08.039.

15.

Long-term outcome after statin treatment in routine clinical practice: results from a prospective PCI cohort study.

Eindhoven JA, Onuma Y, Oemrawsingh RM, Daemen J, van Nierop JW, de Jaegere PP, Boersma E, Serruys PW, van Domburg RT.

EuroIntervention. 2012 Apr;7(12):1420-7. doi: 10.4244/EIJV7I12A222.

16.

Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.

Stypmann J, Schubert A, Welp H, Schulte H, Assmann G, Breithardt G, Nofer JR.

Clin Cardiol. 2008 Oct;31(10):478-81. doi: 10.1002/clc.20273.

17.

Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure.

Xie RQ, Cui W, Liu F, Yang C, Pei WN, Lu JC.

Int J Cardiol. 2010 Apr 15;140(2):255-7. doi: 10.1016/j.ijcard.2008.11.030. Epub 2008 Nov 29.

PMID:
19042044
18.

The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K.

Sever PS, Chang CL, Gupta AK, Whitehouse A, Poulter NR; ASCOT Investigators.

Eur Heart J. 2011 Oct;32(20):2525-32. doi: 10.1093/eurheartj/ehr333. Epub 2011 Aug 28.

19.

[Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].

Núñez J, Sanchis J, Núñez E, Fonarow GC, Bodí V, Bertomeu-González V, Miñana G, Palau P, Fácila L, Chorro FJ, Bertomeu-Martínez V, Llàcer A.

Rev Esp Cardiol. 2011 Dec;64(12):1100-8. doi: 10.1016/j.recesp.2011.05.029. Epub 2011 Sep 28. Spanish.

20.

Statin use in COPD patients is associated with a reduction in mortality: a national cohort study.

Lawes CM, Thornley S, Young R, Hopkins R, Marshall R, Chan WC, Jackson G.

Prim Care Respir J. 2012 Mar;21(1):35-40. doi: 10.4104/pcrj.2011.00095.

Items per page

Supplemental Content

Write to the Help Desk